Shiraki K, Ogino T, Yamamoto T, Yamanishi K, Takahashi M
Biken J. 1986 Mar;29(1):11-7.
The DNA polymerase activity, and susceptibilities to 9-beta-D-arabinofuranosyladenine(ara-A) and 1-beta-arabinofuranosylcytosine(ara-C) of a phosphonoacetic acid resistant mutant (PAA-R) of varicella-zoster virus (VZV) selected in the presence of PAA were examined. The DNA polymerase activity of PAA-R was inhibited less than that of the parent strain by PAA in vitro. PAA-R was resistant to acyclovir and also to both ara-A and ara-C. The susceptibilities to ara-A and ara-C of four acyclovir resistant mutants selected in the presence of acyclovir, and also resistant to PAA, were examined. Two variants were resistant, one was slightly resistant, and one was sensitive to both drugs. These cross-resistances and susceptibilities of VZV variants to PAA, ACV, ara-A and ara-C should be considered in chemotherapy of VZV infections.
检测了在膦甲酸(PAA)存在下选择的水痘-带状疱疹病毒(VZV)的膦甲酸抗性突变体(PAA-R)的DNA聚合酶活性以及对9-β-D-阿拉伯呋喃糖基腺嘌呤(ara-A)和1-β-阿拉伯呋喃糖基胞嘧啶(ara-C)的敏感性。在体外,PAA对PAA-R的DNA聚合酶活性的抑制作用小于对亲本菌株的抑制作用。PAA-R对阿昔洛韦以及ara-A和ara-C均具有抗性。检测了在阿昔洛韦存在下选择的、对PAA也具有抗性的四个阿昔洛韦抗性突变体对ara-A和ara-C的敏感性。两个变体具有抗性,一个略有抗性,一个对两种药物均敏感。在VZV感染的化疗中应考虑VZV变体对PAA、阿昔洛韦、ara-A和ara-C的这些交叉抗性和敏感性。